Bristol-Myers Squibb Company
2-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors
Last updated:
Abstract:
The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicament. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
5 Jun 2017
Issue date:
24 Mar 2020